" class="no-js "lang="en-US"> Keegan Nees, IMMY, on Fungal Infection Diagnostics
Thursday, June 08, 2023

Breaking News

SciTech Development Raises $2.73 Million in Oversubscribed Funding Round to Advance Clinical Trials for Cancer Treatment Amarna Therapeutics Announces Appointment of Dr. Henk Streefkerk as New CEO Aegis Life Awarded Grant to Develop DNA-encoded Antibodies Against Infectious Diseases New “AI Doctor” Predicts Hospital Readmission and Other Health Outcomes Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell-Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease MedTech Innovator Asia Pacific Names 24 Startups to Annual Accelerator XNK Therapeutics Appoints Hugo Petit as Chief Financial Officer Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics Abivax Appoints Ida Hatoum as Chief People Officer Eureka Therapeutics Awarded $10.6 Million CIRM Grant to Support Clinical Trial of ARTEMIS® T-Cell Therapy in Pediatric Liver Cancer

May 18 2023

Keegan Nees, IMMY, on Fungal Infection Diagnostics

We caught up with Keegan Nees, a Product Marketing Strategist from IMMY, at ECCMID, who discusses his company’s focus on fungal infection diagnostics. He explains that IMMY is dedicated to developing innovative solutions for the accurate and timely diagnosis of fungal infections.

Nees emphasizes the significance of fungal infections, highlighting their prevalence and the challenges they pose in terms of diagnosis and treatment. He emphasizes that early and accurate detection is crucial for effective management of these infections.

  1. SciTech Development Raises $2.73 Million in Oversubscribed Funding Round to Advance Clinical Trials for Cancer Treatment

    Clinical Trials

     Read more
  2. Amarna Therapeutics Announces Appointment of Dr. Henk Streefkerk as New CEO

    Appointments

     Read more
  3. Aegis Life Awarded Grant to Develop DNA-encoded Antibodies Against Infectious Diseases

    Diseases

     Read more
  4. New “AI Doctor” Predicts Hospital Readmission and Other Health Outcomes

    News

     Read more
  5. Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell-Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease

    Clinical Trials

     Read more
More On